MARSHEA LIDDELL: Open Payments
NPI 1528473261 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,727 in 136 payments from 16 companies in 2025. Trend: 2023 $1,720 · 2024 $2,353 · 2025 $2,727
Food & beverage: $2,727
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $692 |
| Aimmune Therapeutics, Inc. | 13 | $347 |
| Janssen Biotech, Inc. | 19 | $329 |
| Ardelyx, Inc. | 12 | $303 |
| GENZYME CORPORATION | 10 | $255 |
| Ipsen Biopharmaceuticals, Inc | 5 | $221 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $215 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $138 |
| Lilly USA, LLC | 4 | $68 |
| Phathom Pharmaceuticals, Inc. | 6 | $49 |
Products named: ZENPEP, TREMFYA, RINVOQ, IBSRELA, DUPIXENT, IQIRVO, XIFAXAN, SKYRIZI.
Industry payments across MS — which companies pay providers there.
